Nuveen Asset Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,476
| Closed | -$284K | – | 3382 |
|
|
2024
Q1 | $284K | Hold |
31,476
| – | – | ﹤0.01% | 3113 |
|
|
2023
Q4 | $298K | Buy |
31,476
+119
| +0.4% | +$1.13K | ﹤0.01% | 3149 |
|
|
2023
Q3 | $373K | Sell |
31,357
-158
| -0.5% | -$1.88K | ﹤0.01% | 2927 |
|
|
2023
Q2 | $772K | Sell |
31,515
-23,619
| -43% | -$579K | ﹤0.01% | 2759 |
|
|
2023
Q1 | $1.73M | Sell |
55,134
-70,595
| -56% | -$2.21M | ﹤0.01% | 2395 |
|
|
2022
Q4 | $8.85M | Sell |
125,729
-12,001
| -9% | -$845K | ﹤0.01% | 1576 |
|
|
2022
Q3 | $11.9M | Buy |
137,730
+80,054
| +139% | +$6.89M | ﹤0.01% | 1372 |
|
|
2022
Q2 | $4.77M | Buy |
57,676
+43,424
| +305% | +$3.59M | ﹤0.01% | 1976 |
|
|
2022
Q1 | $2.11M | Sell |
14,252
-3,650
| -20% | -$540K | ﹤0.01% | 2480 |
|
|
2021
Q4 | $2.18M | Buy |
17,902
+562
| +3% | +$68.5K | ﹤0.01% | 2528 |
|
|
2021
Q3 | $1.69M | Sell |
17,340
-377
| -2% | -$36.7K | ﹤0.01% | 2752 |
|
|
2021
Q2 | $962K | Buy |
17,717
+215
| +1% | +$11.7K | ﹤0.01% | 3024 |
|
|
2021
Q1 | $1.04M | Buy |
17,502
+937
| +6% | +$55.8K | ﹤0.01% | 2871 |
|
|
2020
Q4 | $865K | Sell |
16,565
-109
| -0.7% | -$5.69K | ﹤0.01% | 2858 |
|
|
2020
Q3 | $807K | Buy |
16,674
+3,373
| +25% | +$163K | ﹤0.01% | 2777 |
|
|
2020
Q2 | $689K | Buy |
13,301
+2,173
| +20% | +$113K | ﹤0.01% | 2784 |
|
|
2020
Q1 | $486K | Buy |
11,128
+7,037
| +172% | +$307K | ﹤0.01% | 2777 |
|
|
2019
Q4 | $164K | Sell |
4,091
-2,013
| -33% | -$80.7K | ﹤0.01% | 3089 |
|
|
2019
Q3 | $200K | Buy |
6,104
+1,621
| +36% | +$53.1K | ﹤0.01% | 3123 |
|
|
2019
Q2 | $346K | Buy |
+4,483
| New | +$346K | ﹤0.01% | 3081 |
|